[go: up one dir, main page]

DK1549650T3 - Substituerede C-imidazo[1,2-a]pyridin-3yl-methylaminer - Google Patents

Substituerede C-imidazo[1,2-a]pyridin-3yl-methylaminer

Info

Publication number
DK1549650T3
DK1549650T3 DK03807842T DK03807842T DK1549650T3 DK 1549650 T3 DK1549650 T3 DK 1549650T3 DK 03807842 T DK03807842 T DK 03807842T DK 03807842 T DK03807842 T DK 03807842T DK 1549650 T3 DK1549650 T3 DK 1549650T3
Authority
DK
Denmark
Prior art keywords
alkyl
cycloalkyl
optionally
methylcyclobutyl
methylcyclopropyl
Prior art date
Application number
DK03807842T
Other languages
Danish (da)
English (en)
Inventor
Hagen-Heinrich Hennies
Bernd Sundermann
Stefan Oberboersch
Corinna Sundermann
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Application granted granted Critical
Publication of DK1549650T3 publication Critical patent/DK1549650T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK03807842T 2002-10-08 2003-10-06 Substituerede C-imidazo[1,2-a]pyridin-3yl-methylaminer DK1549650T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10246890A DE10246890A1 (de) 2002-10-08 2002-10-08 Substituierte C-Imidazo[1,2-alpyridin-3-yl-methylamine

Publications (1)

Publication Number Publication Date
DK1549650T3 true DK1549650T3 (da) 2006-07-31

Family

ID=32038330

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03807842T DK1549650T3 (da) 2002-10-08 2003-10-06 Substituerede C-imidazo[1,2-a]pyridin-3yl-methylaminer

Country Status (10)

Country Link
US (1) US7342025B2 (es)
EP (1) EP1549650B1 (es)
AT (1) ATE321046T1 (es)
AU (1) AU2003300132A1 (es)
CY (1) CY1105019T1 (es)
DE (2) DE10246890A1 (es)
DK (1) DK1549650T3 (es)
ES (1) ES2260693T3 (es)
PT (1) PT1549650E (es)
WO (1) WO2004033453A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10050663A1 (de) * 2000-10-13 2002-04-18 Gruenenthal Gmbh Verwendung von substituierten Imidazo[1,2-a]pyridin-, -pyrimidin- und pyrazin-3-yl-amin-Derivaten zur Herstellung von Medikamenten zur NOS-Inhibierung
DE10247269A1 (de) * 2002-10-10 2004-04-22 Grünenthal GmbH Substituierte C-Imidazo[1,2-a]pyridin-3-yl-methylamine
ES2761180T3 (es) 2005-12-23 2020-05-19 Ariad Pharma Inc Compuestos bicíclicos de heteroarilo
US8236841B2 (en) 2006-09-13 2012-08-07 Kyowa Hakko Kirin Co., Ltd. Fused heterocycle derivative
EP1964840A1 (en) * 2007-02-28 2008-09-03 sanofi-aventis Imidazo[1,2-a]pyridines and their use as pharmaceuticals
HRP20130660T1 (en) * 2007-04-03 2013-08-31 Array Biopharma, Inc. Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors
EP2671582B1 (en) 2011-02-01 2016-07-13 Kyowa Hakko Kirin Co., Ltd. Ring-fused heterocyclic derivative
EP2881394B1 (en) 2012-07-31 2018-03-21 Kyowa Hakko Kirin Co., Ltd. Condensed ring heterocyclic compound
CN104628721A (zh) * 2015-01-22 2015-05-20 湖南华腾制药有限公司 一种咪唑并[1,2-a]吡啶衍生物的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1536351A (fr) * 1967-07-03 1968-08-27 Pyridylimidazopyridines
JPH11505524A (ja) * 1995-05-01 1999-05-21 藤沢薬品工業株式会社 イミダゾ1,2−aピリジンおよびイミダゾ1,2−aピリデジン誘導体、および骨吸収阻害剤としてのその用途
DE19734184A1 (de) * 1997-08-07 1999-02-11 Agfa Gevaert Ag Fotografisches Silberhalogenidmaterial
DE19948434A1 (de) * 1999-10-08 2001-06-07 Gruenenthal Gmbh Substanzbibliothek enthaltend bicyclische Imidazo-5-amine und/oder bicyclische Imidazo-3-amine
DE10040016A1 (de) * 2000-08-16 2002-02-28 Boehringer Ingelheim Pharma Neue beta-Amyloid Inhibitoren, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
US6514969B2 (en) 2000-08-16 2003-02-04 Boehringer Ingelheim Pharma Kg β-amyloid inhibitors, processes for preparing them, and their use in pharmaceutical compositions
SE0100567D0 (sv) * 2001-02-20 2001-02-20 Astrazeneca Ab Compounds
SE0100568D0 (sv) * 2001-02-20 2001-02-20 Astrazeneca Ab Compounds
DE10247269A1 (de) * 2002-10-10 2004-04-22 Grünenthal GmbH Substituierte C-Imidazo[1,2-a]pyridin-3-yl-methylamine

Also Published As

Publication number Publication date
ATE321046T1 (de) 2006-04-15
US7342025B2 (en) 2008-03-11
DE50302769D1 (de) 2006-05-11
WO2004033453A1 (de) 2004-04-22
DE10246890A1 (de) 2004-04-22
EP1549650A1 (de) 2005-07-06
ES2260693T3 (es) 2006-11-01
AU2003300132A1 (en) 2004-05-04
EP1549650B1 (de) 2006-03-22
PT1549650E (pt) 2006-07-31
CY1105019T1 (el) 2009-11-04
US20050239822A1 (en) 2005-10-27

Similar Documents

Publication Publication Date Title
DK1549647T3 (da) Substituerede C-imidazo[1,2-a]pyridin-3-yl-methylaminer
DK1549650T3 (da) Substituerede C-imidazo[1,2-a]pyridin-3yl-methylaminer
NO20001886L (no) Stabile, krystallinske salter av 5-metyltetrahydrofolsyre og fremgangsmÕte til fremstilling derav
YU108791A (sh) Pirazolopirimidinon antianginalna jedinjenja
LV12208A (lv) Hiv proteazes inhibitora pielietojums aids arstesanai
HRP20090280T1 (hr) Derivati fenoksioctene kiseline
HRP20161547T1 (hr) Derivati 5-fluor-n-(piridin-2-il)piridin-2-amina koji sadrže sulfoksiminsku skupinu
DE69720965D1 (de) Chinazolinderivate und deren verwendung als vegf hemmer
YU30491A (sh) Derivati 1-piridilimidazola i njegova proizvodnja i upotreba
ES2037738T3 (es) Procedimiento para la obtencion de aminopirazinonas y aminotriazinonas.
NO20054080L (no) Aminoheteroarylforbindelser som roteinkinaseinhibitorer
FI900839A0 (fi) Substituoidut pyrimidiinijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö väliaineina
NO20051448L (no) Makrosykliske pyrimidiner, fremstilling derav og anvendelse av de samme som medikamenter
DE3870338D1 (de) Dhp-manteltablette.
TW200700387A (en) 1-benzylindole-2-carboxamide derivatives
IL135924A0 (en) Urea derivatives and their use as integrin inhibitors
NO20076681L (no) Ny metode for fremstilling av tiotropiumsalter
HUP0402282A2 (hu) Triazolo[1,5-a]kinolin-származékok, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények
CA2445625A1 (en) Pyrazino'1',2':1,6!pyrido'3,4-b!indole1,4-dione derivatives
HRP20070063T3 (hr) POSTUPAK DOBIVANJA SUPSTITUIRANIH 5-AMINOPIRAZOLO[4,3-e]-1,2,4-TRIAZOLO[1,5-c]PIRIMIDINA
AR018868A1 (es) Composiciones farmaceuticas para la fragilidad musculoesqueletica, uso para la preparacion de medicamentos, estuche
IL119054A (en) Substituted 4H-pyrans their preparation and pharmaceutical compositions containing them
YU227986A (en) Process for obtaining new pyrimido/5,4-b//1,4/oxazine derivatives
CY1112161T1 (el) Σταθερο κρυσταλλικο μετα ασβεστιου αλας toy 5-meθyλo-(6s)- τετραϋδροφολικου οξεος
HUP9902890A2 (hu) Szubsztituált pirimidinszármazékok és gyógyászati felhasználásuk